These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23434433)

  • 1. Antibody-mediates inhibition of human C1s and the classical complement pathway.
    Carroll S; Georgiou G
    Immunobiology; 2013 Aug; 218(8):1041-8. PubMed ID: 23434433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.
    Duncan RC; Mohlin F; Taleski D; Coetzer TH; Huntington JA; Payne RJ; Blom AM; Pike RN; Wijeyewickrema LC
    J Immunol; 2012 Sep; 189(5):2365-73. PubMed ID: 22855709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate.
    Rossi V; Bally I; Thielens NM; Esser AF; Arlaud GJ
    J Biol Chem; 1998 Jan; 273(2):1232-9. PubMed ID: 9422791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2.
    Thielens NM; Villiers CL; Villiers MB; Colomb MG
    FEBS Lett; 1984 Jan; 165(1):111-6. PubMed ID: 6319179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding.
    Rossi V; Bally I; Ancelet S; Xu Y; Frémeaux-Bacchi V; Vivès RR; Sadir R; Thielens N; Arlaud GJ
    J Immunol; 2010 May; 184(9):4982-9. PubMed ID: 20351192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
    O'Brien G; Quinsey NS; Whisstock JC; Pike RN
    Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.
    Goers JW; Porter RR
    Biochem J; 1978 Nov; 175(2):675-84. PubMed ID: 743217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4.
    Perry AJ; Wijeyewickrema LC; Wilmann PG; Gunzburg MJ; D'Andrea L; Irving JA; Pang SS; Duncan RC; Wilce JA; Whisstock JC; Pike RN
    J Biol Chem; 2013 May; 288(22):15821-9. PubMed ID: 23592783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro stimulation of C1s proteolytic activities by C1s-presenting autoantibodies from patients with systemic lupus erythematosus.
    He S; Lin YL
    J Immunol; 1998 May; 160(9):4641-7. PubMed ID: 9574573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
    Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
    Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52.
    Redpath S; Michaelsen T; Sandlie I; Clark MR
    Immunology; 1998 Apr; 93(4):595-600. PubMed ID: 9659234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study.
    Wahrmann M; Mühlbacher J; Marinova L; Regele H; Huttary N; Eskandary F; Cohen G; Fischer GF; Parry GC; Gilbert JC; Panicker S; Böhmig GA
    Am J Transplant; 2017 Sep; 17(9):2300-2311. PubMed ID: 28251805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
    Vorup-Jensen T; Jensenius JC; Thiel S
    Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.